# ClinicalTrials.gov record history: NCT03035032

- Peptide profile: [leuprolide](https://peptidescanner.com/peptides/leuprolide/)
- Human timeline: https://peptidescanner.com/stories/clinicaltrials-gov-nct03035032-leuprolide/
- JSON object: https://peptidescanner.com/clinical-trials-history/v1/trials/nct03035032.json
- Source observed: 2026-08-23T23:32:33.000Z
- Published by PeptideScanner: 2026-08-23
- Source observation SHA-256: `6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e`
- Object content SHA-256: `3501743b388829d800c0d6052d85deba463513706e1ba4cfed1938f69ffd2ef3`

## Reporting boundary

ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.

## Public history versions

| Version | Submitted | Last submitted QC | Status | Study type | Source-declared changed modules | Exact source | Record SHA-256 |
| ---: | --- | --- | --- | --- | --- | --- | --- |
| 1 | 2017-01-25 | 2017-01-25 | NOT_YET_RECRUITING | INTERVENTIONAL | None listed | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=1&tab=history) | `4e16944e8de43d5874aacfdae43930204602b532e2a17d916fc0abd9fa86ce74` |
| 2 | 2017-02-08 | 2017-02-08 | NOT_YET_RECRUITING | INTERVENTIONAL | Arms and Interventions, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=2&tab=history) | `21eea2c0c126523994aa4d627e74d7e585dda5668431416b5791530254913689` |
| 3 | 2017-03-15 | 2017-03-15 | NOT_YET_RECRUITING | INTERVENTIONAL | Sponsor/Collaborators, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=3&tab=history) | `0c2cafedc08be4da403ecb7a642f0b8c5549dc5cd0d6cc707c5a7b34a7a3971a` |
| 4 | 2017-04-11 | 2017-04-11 | NOT_YET_RECRUITING | INTERVENTIONAL | Outcome Measures, Oversight, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=4&tab=history) | `351f23563141c0d8029bbafb6600153eb3c67ed2e591d1f312c9c099034fdf98` |
| 5 | 2017-07-20 | 2017-07-20 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=5&tab=history) | `83d913c6395962b4f24330fe1e2e2e46b24b10150e6ad5e8b469f279a9b4e0a7` |
| 6 | 2017-08-09 | 2017-08-09 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=6&tab=history) | `a0f37eeb306747c1f32d349a81e3f8d8e9b2a5ee9bdd1f4269d83f4cc25720c9` |
| 7 | 2017-09-05 | 2017-09-05 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=7&tab=history) | `e515c49155443b2cd38ae27b8c2e24b544297fb31275f689afbdbd4e8c49586d` |
| 8 | 2017-10-11 | 2017-10-11 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=8&tab=history) | `bd1c4037c624728de8156802bed89c7d4cb5808ad9afac59e0d63a7c401aa76c` |
| 9 | 2017-11-21 | 2017-11-21 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=9&tab=history) | `81440a9606a364786e0d09568918a72d84ad854281a5e7d396e3503f7c57ed7e` |
| 10 | 2018-01-23 | 2018-01-23 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=10&tab=history) | `97b727a8fdae6edc16901c7e21a007ef4a226ed6fbf7f28b90162a8802ce76ff` |
| 11 | 2018-03-22 | 2018-03-22 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Eligibility, Study Design, Study Identification, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=11&tab=history) | `d8ac63b2f6a012ab59331fa76cbaac2479e8d7d557589148fd1079be0f2deedc` |
| 12 | 2018-05-08 | 2018-05-08 | RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=12&tab=history) | `d4fcebcde382e1b9773c93200031ea85cddb1e71af25f95696ce8d40bd7a7a6e` |
| 13 | 2018-05-29 | 2018-05-29 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Contacts/Locations, Study Design, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=13&tab=history) | `9850a2c6ba54c523f755e7cc27c2000a0488ba6ac54f12591076980e1070196d` |
| 14 | 2018-09-25 | 2018-09-25 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=14&tab=history) | `43efc516b6d4309189942f267020b5cd13148eba1b68b004014441c6b27f160e` |
| 15 | 2019-03-19 | 2019-03-19 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=15&tab=history) | `089dfb031db098fe4c8b53820adb2bf164c1c519f85ef40621e46f85bc6e8095` |
| 16 | 2019-09-09 | 2019-09-09 | ACTIVE_NOT_RECRUITING | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=16&tab=history) | `1ed9ff088a61e9cba3b126111dd4810c03b43941879bbc6d0472d50470b07404` |
| 17 | 2019-12-02 | 2019-12-02 | COMPLETED | INTERVENTIONAL | Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=17&tab=history) | `c43fc3b9ee50d5e5aa64d19b51d0254c9c09653cb8152d1866dc3708e819f692` |
| 18 | 2020-02-07 | 2020-02-07 | COMPLETED | INTERVENTIONAL | IPDSharing, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=18&tab=history) | `cb79f379b8d611edce6767a16389016a228b3fed8599df58a70679684d7c975f` |
| 19 | 2020-11-13 | 2020-11-13 | COMPLETED | INTERVENTIONAL | Adverse Events, Arms and Interventions, Baseline Characteristics, Document Section, More Information, Outcome Measures, Outcome Measures (Results), Participant Flow, Study Description, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=19&tab=history) | `23c14fb22228b25c079268ee79524918eac46126d7e422e06990e52e8d2ddd02` |
| 20 | 2021-01-17 | 2021-01-17 | COMPLETED | INTERVENTIONAL | Baseline Characteristics, Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=20&tab=history) | `bc18be480b30acfa4ad76a370fd6495ba90603e7929a85dfc3951c9081daa312` |
| 21 | 2024-11-08 | 2024-11-08 | COMPLETED | INTERVENTIONAL | IPDSharing, Outcome Measures, Outcome Measures (Results), Study Status | [ClinicalTrials.gov](https://clinicaltrials.gov/study/NCT03035032?a=21&tab=history) | `8e10a9a67a726217af7fcbf027a2ea12a8ee56efe69f26f410278233a0e52277` |